Business Description
Edwards Lifesciences Corp
NAICS : 339113
SIC : 3842
ISIN : US28176E1082
Share Class Description:
EW: Ordinary SharesDescription
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, and catheters. The firm derives about 55% of its total sales from outside the US.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 6.29 | |||||
| Equity-to-Asset | 0.74 | |||||
| Debt-to-Equity | 0.07 | |||||
| Debt-to-EBITDA | 0.38 | |||||
| Interest Coverage | 102.74 | |||||
| Piotroski F-Score | 7/9 | |||||
| Altman Z-Score | 10.52 | |||||
| Beneish M-Score | -1.21 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 12.4 | |||||
| 3-Year EBITDA Growth Rate | 20.6 | |||||
| 3-Year EPS without NRI Growth Rate | 10.5 | |||||
| 3-Year FCF Growth Rate | 0.3 | |||||
| 3-Year Book Growth Rate | 14.7 |
Momentum Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 64.3 | |||||
| 9-Day RSI | 62.68 | |||||
| 14-Day RSI | 61.27 | |||||
| 3-1 Month Momentum % | -1.36 | |||||
| 6-1 Month Momentum % | -23.08 | |||||
| 12-1 Month Momentum % | -4.26 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 3.46 | |||||
| Quick Ratio | 2.89 | |||||
| Cash Ratio | 2.29 | |||||
| Days Inventory | 254.81 | |||||
| Days Sales Outstanding | 42.33 | |||||
| Days Payable | 44.32 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 1.3 | |||||
| Shareholder Yield % | 3.46 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 75.97 | |||||
| Operating Margin % | 27.4 | |||||
| Net Margin % | 63.02 | |||||
| FCF Margin % | 7.43 | |||||
| ROE % | 55.59 | |||||
| ROA % | 40.35 | |||||
| ROIC % | 22.84 | |||||
| 3-Year ROIIC % | 19.61 | |||||
| ROC (Joel Greenblatt) % | 60.77 | |||||
| ROCE % | 18.91 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 10.59 | |||||
| Forward PE Ratio | 30.25 | |||||
| PE Ratio without NRI | 27.49 | |||||
| Shiller PE Ratio | 32.33 | |||||
| Price-to-Owner-Earnings | 11.83 | |||||
| PEG Ratio | 1.56 | |||||
| PS Ratio | 6.72 | |||||
| PB Ratio | 4.54 | |||||
| Price-to-Tangible-Book | 6.2 | |||||
| Price-to-Free-Cash-Flow | 90.05 | |||||
| Price-to-Operating-Cash-Flow | 54.81 | |||||
| EV-to-EBIT | 23.33 | |||||
| EV-to-Forward-EBIT | 25.2 | |||||
| EV-to-EBITDA | 21.44 | |||||
| EV-to-Forward-EBITDA | 22.62 | |||||
| EV-to-Revenue | 5.99 | |||||
| EV-to-Forward-Revenue | 6.76 | |||||
| EV-to-FCF | 80.69 | |||||
| Price-to-GF-Value | 0.81 | |||||
| Price-to-Projected-FCF | 2.14 | |||||
| Price-to-DCF (Earnings Based) | 0.98 | |||||
| Price-to-DCF (FCF Based) | 6.67 | |||||
| Price-to-Median-PS-Value | 0.75 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.97 | |||||
| Price-to-Graham-Number | 2.77 | |||||
| Price-to-Net-Current-Asset-Value | 13.18 | |||||
| Price-to-Net-Cash | 42.66 | |||||
| Earnings Yield (Greenblatt) % | 4.29 | |||||
| FCF Yield % | 1.13 | |||||
| Forward Rate of Return (Yacktman) % | 15.98 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NYSE:EW
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Edwards Lifesciences Corp Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 6,599.7 | ||
| EPS (TTM) ($) | 6.93 | ||
| Beta | 1.02 | ||
| 3-Year Sharpe Ratio | -0.3 | ||
| 3-Year Sortino Ratio | -0.38 | ||
| Volatility % | 43.74 | ||
| 14-Day RSI | 61.27 | ||
| 14-Day ATR ($) | 2.103358 | ||
| 20-Day SMA ($) | 70.308 | ||
| 12-1 Month Momentum % | -4.26 | ||
| 52-Week Range ($) | 58.93 - 96.12 | ||
| Shares Outstanding (Mil) | 589.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 7 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Edwards Lifesciences Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Edwards Lifesciences Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Edwards Lifesciences Corp Frequently Asked Questions
What is Edwards Lifesciences Corp(EW)'s stock price today?
The current price of EW is $73.81. The 52 week high of EW is $96.12 and 52 week low is $58.93.
When is next earnings date of Edwards Lifesciences Corp(EW)?
The next earnings date of Edwards Lifesciences Corp(EW) is 2025-02-06 Est..
Does Edwards Lifesciences Corp(EW) pay dividends? If so, how much?
Edwards Lifesciences Corp(EW) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers